Treatment for Cardiogenic Shock due to Pulmonary Embolism

Initial Stabilization Measures

The European Society of Cardiology recommends initiating unfractionated heparin (UFH) immediately without delay in patients with high-risk PE presenting with cardiogenic shock, using a weight-adjusted regimen: 80 U/kg bolus followed by infusion at 18 U/kg/h, and adjusting subsequent doses using aPTT-based nomogram (target 1.5-2.5 times normal) 2, 3
Addressing systemic hypotension to prevent progression of right ventricular failure is crucial, and vasopressors (norepinephrine) and/or dobutamine are recommended for hypotensive patients with PE, while avoiding aggressive fluid challenge as it may worsen right ventricular function 1, 2
Providing oxygen therapy to patients with hypoxemia is essential 1

The European Society of Cardiology recommends systemic thrombolysis for high-risk PE with cardiogenic shock and/or persistent arterial hypotension (Class I, Level A recommendation), with approved thrombolytic regimens including rtPA, streptokinase, and urokinase 1, 2
Most contraindications for thrombolytic therapy in massive PE are relative rather than absolute, and thrombolysis should be based on objective diagnostic tests 4

Surgical pulmonary embolectomy is indicated when thrombolysis is contraindicated or has failed (Class I, Level C recommendation), and involves median sternotomy with rapid cannulation of ascending aorta and right atrium, institution of normothermic cardiopulmonary bypass, and removal of emboli via longitudinal incision in main pulmonary artery 2, 4, 5

Catheter-directed interventions should be considered for patients with high-risk PE when thrombolysis is contraindicated or has failed (Class IIa, Level C recommendation), with options including catheter embolectomy or fragmentation of proximal pulmonary arterial clots 1, 2

ECMO may be considered in combination with surgical embolectomy or catheter-directed treatment in patients with PE and refractory circulatory collapse or cardiac arrest (Class IIb, Level C recommendation), providing excellent resuscitation in cardiogenic shock by restoring blood flow and oxygen delivery to tissues 2, 4

Delay in initiating appropriate therapy significantly increases mortality in high-risk PE, and thrombolytic therapy is most effective when initiated within 48 hours of symptom onset 1, 2
Unsuccessful thrombolysis occurs in approximately 8% of high-risk PE patients, and the risk/benefit ratio of each intervention must be carefully assessed, especially in patients with contraindications to anticoagulation or thrombolysis 1, 2

After hemodynamic stabilization, continuing with anticoagulation treatment as in intermediate or low-risk PE is recommended, and considering long-term anticoagulation to prevent recurrent events 1, 5